Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate plus Immunace vs methotrexate alone in psoriasis vulgaris
IRCT2014012016275N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of methotrexate in plaque psoriasis (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Improvement of psoriasis vulgaris. Started Jan 2014; status: completed.
02
Drugs
methotrexate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on IRCT2014012016275N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014012016275N1.